Arcutis Biotherapeutics
Latest round
- Series C
Last raised
- Oct 2019
Total raised
- $166M
Investors
- 10
About Arcutis Biotherapeutics
Based in California, US and founded in 2016, Arcutis Biotherapeutics, Inc. develops and commercializes novel immuno-dermatology drugs intended for patients with skin conditions. The company was co-founded by Bhaskar Chaudhuri and David W. Osborne. In October 2023, Arcutis Biotherapeutics, Inc.23 per share on the Nasdaq Global Select Market under the ticker symbol "ARQT". Arcutis Biotherapeutics, Inc. has granted the underwriters a 30-day option to purchase up to an additional 15 million shares of common stock as part of the listing. The company works with pharmaceutical companies, by offering immuno-dermatology drugs for patients with skin conditions. Arcutis Biotherapeutics, Inc. develops novel treatments for skin conditions such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, scalp psoriasis, hand eczema, vitiligo, and alopecia areata. Products include ARQ-151 - for plaque and atopic dermatitis, ARQ-154 – for seborrheic dermatitis and scalp psoriasis, ARQ-252 – for hand eczema and vitiligo, and ARQ-255 – for alopecia areata. The company will show the different drugs development to pharmaceutical companies, then the latter will negotiate, purchase, and manufacture the drugs. The products can then be purchased by the public.’s revenue will be generated by selling the developed treatment, intended for patients with skin conditions, to pharmaceutical companies.
Who invested in Arcutis Biotherapeutics
10 investors across 3 rounds
See all investors in Arcutis Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arcutis Biotherapeutics
Who invested in Arcutis Biotherapeutics?
Arcutis Biotherapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arcutis Biotherapeutics raised?
Arcutis Biotherapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arcutis Biotherapeutics last raise money?
Arcutis Biotherapeutics's most recent round on record is a Series C, in Oct 2019.
What does Arcutis Biotherapeutics do?
Based in California, US and founded in 2016, Arcutis Biotherapeutics, Inc.
Where is Arcutis Biotherapeutics headquartered?
Arcutis Biotherapeutics is headquartered in Westlake Village, US.
Which VCs invest in companies like Arcutis Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arcutis Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Arcutis Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.